Skip to main content
Clinical Trials/NCT00583414
NCT00583414
Completed
Not Applicable

Endovascular Exclusion of Abdominal Aortic Aneurysms in High Risk Patients

The Cleveland Clinic1 site in 1 country401 target enrollmentSeptember 1998

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Abdominal Aortic Aneurysm
Sponsor
The Cleveland Clinic
Enrollment
401
Locations
1
Primary Endpoint
Freedom From Aneurysm Rupture
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The purpose of this study is to assess the role of abdominal aneurysm and iliac aneurysm exclusion using an endovascular prosthesis.

Detailed Description

This study is a prospective, non-randomized evaluation of endovascular aneurysm repair in high-risk patients. The purpose of this study is to determine whether this endovascular prosthesis is safe and effective for the intended use of treating AAA/iliac aneurysm in patients who are at high risk for standard aneurysm surgical repair. Up to 400 patients will be enrolled at the Cleveland clinic Foundation. Baseline procedures may include angiogram, intravascular ultrasound, CT scan, physical exam, blood work and ankle-brachial index. The endovascular prosthesis is placed in the operating room under regional or general anesthesia and the procedure length is approximately 2-3 hours. Follow up evaluations will be done at 1 month, 6 months (if clinically necessary), 12 months and yearly, and may include a physical exam, CT scan, KUB, ultrasound, blood work, and an ankle-brachial index.

Registry
clinicaltrials.gov
Start Date
September 1998
End Date
October 2017
Last Updated
7 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Federico Ezequiel Parodi

Staff

The Cleveland Clinic

Eligibility Criteria

Inclusion Criteria

  • The aneurysm is \>/= 5 cm or larger, or with a high risk of rupture due to its shape, history of growth, symptoms, or the presence of a large (\>2 cm) iliac aneurysm
  • Anticipated mortality greater than 10 percent with conventional surgery
  • Life expectancy greater than 2 years
  • Suitable arterial anatomy
  • Absence of systemic disease or allergy that precludes an endovascular repair
  • Capable of giving informed consent and willingness to comply with the follow-up schedule

Exclusion Criteria

  • Pregnancy
  • History of anaphylactic reaction to contrast material with an inability to properly prophylax the patient appropriately
  • Allergy to stainless steel or polyester
  • Unwilling to comply with the follow-up schedule
  • Serious or systemic groin infection
  • Coagulopathy, other than coumadin therapy
  • Inability to give informed consent

Outcomes

Primary Outcomes

Freedom From Aneurysm Rupture

Time Frame: 2 years

Absence of blood extravasation outside of aneurysm sac demonstrated by CT scan

Study Sites (1)

Loading locations...

Similar Trials